UK-based commercialisation firm Frontier IP’s portfolio value registered a 49% rise year-on-year to hit £8m ($11.3m) by the end of December 2017.
Frontier’s latest half-year update showed the company had increased its pre-tax profit by 67% year-on-year to $741,000, a result the firm attributed to its appreciating investments.
Frontier portfolio companies include Heriot-Watt University foodtech spinout Nandi Proteins, which raised $1.3m in July 2017, and Dundee pharmaceutical spinout Exscientia, which secured its first strategic investment of $17.7m in September 2017 from drug discovery company Evotec.
In both cases, Frontier took a stake in partnerships providing access to the universities’ early-stage intellectual property (IP) pipeline. Frontier holds similar deals with institutions such as University of Cambridge and University of Plymouth.
Neil Crabb, chief executive of Frontier IP Group, said: “These encouraging results and, in particular, the near 50% growth in the value our portfolio value year-on-year increasingly demonstrate the…
